Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Hepatitis Warrior Hiking in China Shows Glaxo Hurdles

Lei Chuang trekked almost 1,000 miles over 80 days from Shanghai to Beijing last summer, along riverbanks and highways, to deliver a petition beseeching China’s leaders to cut the prices of hepatitis B drugs. “If drug companies can afford such huge sums for bribing doctors and hospitals, then they should still be profitable if prices are lowered by 50 percent,” said Guangzhou-based Lei, nicknamed the “Hepatitis B Warrior” by Chinese media. “They could use that money to benefit patients instead.”

Published
30 May 2014
From
Bloomberg
Hepatitis B a growing problem in UK prisons

In a written answer to a parliamentary question, Health Minister Norman Lamb said the number of prisoners diagnosed with chronic forms of the virus has risen from just 22 in 2010 to 109 in 2013.

Published
01 May 2014
From
The Independent
Anti-HBV antiretrovirals may help ward off HBV infection in MSM

Three antiretrovirals that also help control hepatitis B virus (HBV) infection—tenofovir, emtricitabine, and lamivudine—may also prevent HBV infection, according to results of a retrospective analysis involving men who have sex with men (MSM) in the Netherlands.

Published
24 April 2014
From
International AIDS Society
Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B

Adding pegylated interferon to entecavir (Baraclude) led to greater hepatitis B virus (HBV) viral load decline and higher likelihood of serological response in people with HBeAg-positive chronic hepatitis

Published
16 April 2014
By
Liz Highleyman
Hepatitis delta virus co-infection increases risk of poor liver-related outcomes for people living with HIV

Co-infection with hepatitis delta virus (HDV) is a major risk factor for hepatic decompensation and liver-related death in people living with HIV, Spanish investigators report in the online

Published
28 March 2014
By
Michael Carter
Booster Shots Needed for People with HIV?

Previous research indicates people with HIV have a reduced immune response to most vaccines, but how does immune response hold up over time—and what are the implications for re-vaccinating with “booster shots”?

Published
26 January 2014
From
BETA blog
China's Struggle With Hepatitis B Discrimination

Job applicants and students are regularly turned down on the basis of the disease. Now, some are fighting back.

Published
04 December 2013
From
The Atlantic
Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure

A dual regimen of entecavir (Baraclude) plus tenofovir (Viread) for 48 weeks led to virological response and was generally well-tolerated among people with chronic hepatitis B who

Published
29 November 2013
By
Liz Highleyman
Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk

Long-term treatment with entecavir can reduce the likelihood that people with chronic hepatitis B will develop hepatocellular carcinoma, according to findings presented this week at The Liver Meeting

Published
06 November 2013
By
Liz Highleyman
Men-only hepatitis B mutation explains higher cancer rates

A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer. Although some women do progress to cirrhosis and liver cancer, the mutation is absent in HBV in women. The research is published ahead of print in the Journal of Clinical Microbiology.

Published
18 October 2013
From
Eurekalert Inf Dis
← First12345...10Next →

Filter by country